Clinical Trials Browser

Phase 2 × cirmtuzumab × Other hematologic neoplasm × Clear all

NCT04501939 2025-09-02

Venetoclax

Phase 2 Active not recruiting

LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell